| Innovations in Instrumentation for Positron Emission Tomography |
15 |
| Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls |
15 |
| Radionuclide Therapy of Metastatic Prostate Cancer |
14 |
| Metabolic Tumor Volume Metrics in Lymphoma |
14 |
| Fever of Unknown Origin: the Value of FDG-PET/CT |
14 |
| PET/MRI Hybrid Systems |
13 |
| SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0 |
12 |
| The Role of PET in Evaluating Atherosclerosis: A Critical Review |
12 |
| Tuberculosis |
11 |
| PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy |
11 |
| From Bench to Bedside-The Bad Berka Experience With First-in-Human Studies |
10 |
| Imaging of Spondylodiscitis |
9 |
| The 3M Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary |
9 |
| Nuclear Imaging in Sarcoidosis |
9 |
| PET/CT Lung Ventilation and Perfusion Scanning using Galligas and Gallium-68-MAA |
8 |
| Clinical Practice Guidelines: Tools to Support High Quality Patient Care |
8 |
| Monitoring Response to Therapy |
8 |
| Neoadjuvant Radiation Lobectomy As an Alternative to Portal Vein Embolization in Hepatocellular Carcinoma |
7 |
| Radiation Imagers for Quantitative, Single-particle Digital Autoradiography of Alpha- and Beta-particle Emitters |
7 |
| PET/CT in Lymphoma: Current Overview and Future Directions |
7 |
| SPECT/CT in Postoperative Painful Hip Arthroplasty |
6 |
| Novel Quantitative PET Techniques for Clinical Decision Support in Oncology |
6 |
| Y-90-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry |
6 |
| Holmium-166 Microsphere Radioembolization of Hepatic Malignancies |
6 |
| Pathogen-Specific Bacterial Imaging in Nuclear Medicine |
6 |
| Radiomics Analysis for Clinical Decision Support in Nuclear Medicine |
6 |
| SPECT/CT in the Postoperative Painful Knee |
5 |
| SPECT/CT in Postoperative Foot and Ankle Pain |
5 |
| PET/MRI in Infection and Inflammation |
5 |
| PET/CT for Staging; Past, Present, and Future |
5 |
| Molecular Imaging and Theranostics-A Multidisciplinary Approach |
4 |
| FDG-PET Imaging in Cervical Cancer |
4 |
| Diagnosis and Monitoring of Osteoporosis With F-18-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future |
4 |
| V/Q SPECT-Normal Values for Lobar Function and Comparison With CT Volumes |
4 |
| SPECT V/Q in Lung Cancer Radiotherapy Planning |
4 |
| Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET |
4 |
| Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic Review |
4 |
| Applications of PET Imaging in the Evaluation of Musculoskeletal Diseases Among the Geriatric Population |
3 |
| SPECT Ventilation Imaging in Asthma |
3 |
| Emergence of Big Data and Its Potential and Current Limitations in Medical Imaging |
3 |
| How to Assess Quality of Primary Research Studies in the Medical Literature? |
3 |
| Knowledge Synthesis in Evidence-Based Medicine |
3 |
| American College of Radiology Appropriateness Criteria: Advancing Evidence-Based Imaging Practice |
3 |
| Currently Available Radiopharmaceuticals for Imaging Infection and the Holy Grail |
3 |
| Radionuclide Imaging of Infection and Inflammation in Children: a Review |
3 |
| Design and Challenges of Radiopharmaceuticals |
3 |
| Novel Target Selection for Nuclear Medicine Studies |
3 |
| PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up |
3 |
| PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma |
3 |
| Molecular Imaging of Inflammatory Arthritis and Related Disorders |
3 |
